James Galbraith: China and Supply Chains – The White House Review’s Focus on US Dependence
Despite brave talk about restoring manufacturing in America, extended supply chains and the position of China are insurmountable impediments.
Read more...Despite brave talk about restoring manufacturing in America, extended supply chains and the position of China are insurmountable impediments.
Read more...Questions about Louisiana’s plans to reroute the mighty Mississppi to save its eroding coast rattle the agency spearheading them
Read more...Sierra Leone so far has had some Covid success despite low vaccination rates, and it illustrates the challenges poor countries face.
Read more...The U.S. Supreme Court’s Monday NCAA antitrust decision opens the door to further more sweeping challenges of the organization’s business model.
Read more...How the ralllying cry of “Follow the science” is looking more and more like sloganeernig as opposed to best practice.
Read more...Managed retreat is a promising way to deal with rising seas…except it requires things we’re bad at, like planning and cooperation.
Read more...Privilege went from an idea discussed by a few activists to a mainstream concept. How does the idea work in practice? What is its history?
Read more...The pandemic is largely to be over in the Global North, at least among the vaccinated…or so it seems.
Read more...A look at the current acceptance of neoliberal policies.
Read more...Mega-corporations are set to win control of global governance of food and agriculture at the UN Food Systems Summit later this year.
Read more...The increasingly dominant Delta variant: Vaccines and transmissibility (especially through children) during “Vaccine Summer.”
Read more...The Framers sought to bad a culture of gift giving. How’s that working out?
Read more...Putin and Biden, side by side.
Read more...United States Supreme Court upholds Obamacare in the third challenge it has heard on the legislation.
Read more...Unions urge Biden and Congress to include expanded Medicare eligibility and prescription drug pricing reform in the infrastructure plan.
Read more...